| Jacob Brekken, PA | |
|
1010 4th St Sw Ste 105, Mason City, IA 50401-2856 | |
| (641) 428-7847 | |
| (641) 428-7999 |
| Full Name | Jacob Brekken |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 1010 4th St Sw Ste 105, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346762341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 88259 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
The first clinical trial funded by the new Efficacy and Mechanism Evaluation (EME) programme will investigate whether a simple procedure to activate one of the body's natural defence mechanisms improves the function of kidneys after transplantation. This research is funded by the Medical Research Council and managed by the National Institute for Health Research.
The Food and Drug Administration (FDA) has given the Blanchette Rockefeller Neurosciences Institute (BRNI) the go-ahead to conduct Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients.
Opioid overdoses take the lives of tens of thousands of Americans annually. Two researchers from Penn State College of Medicine have received nearly $5 million from the National Institutes of Health to study whether an already-approved drug can be used to reduce cravings and prevent relapse in those struggling with opioid addiction.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Brekken, PA 621 S Illinois Ave Ste 103, Mason City, IA 50401-5489 Ph: () - | Jacob Brekken, PA 1010 4th St Sw Ste 105, Mason City, IA 50401-2856 Ph: (641) 428-7847 |
News Archive
The first clinical trial funded by the new Efficacy and Mechanism Evaluation (EME) programme will investigate whether a simple procedure to activate one of the body's natural defence mechanisms improves the function of kidneys after transplantation. This research is funded by the Medical Research Council and managed by the National Institute for Health Research.
The Food and Drug Administration (FDA) has given the Blanchette Rockefeller Neurosciences Institute (BRNI) the go-ahead to conduct Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients.
Opioid overdoses take the lives of tens of thousands of Americans annually. Two researchers from Penn State College of Medicine have received nearly $5 million from the National Institutes of Health to study whether an already-approved drug can be used to reduce cravings and prevent relapse in those struggling with opioid addiction.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
› Verified 7 days ago
Kaitlyn Elizabeth Mcdermitt, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5400 | |
Jennifer E Mccambridge, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-422-6730 Fax: 641-422-6659 | |
Kelty Norton, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 320 N Eisenhower Ave, Mason City, IA 50401 Phone: 641-424-2391 | |
Luan M Bargman, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1010 4th St Sw, Suite 120, Mason City, IA 50401 Phone: 641-428-6020 Fax: 641-428-7803 | |
Shawn M Janssen, P.A Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5360 Fax: 641-494-5361 | |
Kathleen Weishaar, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5210 Fax: 641-494-5214 | |
Kathryn Patricia Kaufman, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1421 4th St Sw, Mason City, IA 50401 Phone: 641-428-2080 Fax: 641-428-5150 |